Do you want to know more about cell and gene therapies (also known as advanced therapies)?
This series of webinars will cover many aspects of cell and gene therapies, from the basics providing an introduction to how this new technology can modify diseases though to a more in-depth look into operational aspects of delivering advanced therapies within the hospital environment. The sessions are delivered as a collaboration between London Advanced Therapies and the ATTC network, as a part of our activities to develop the UK workforce.
This series of webinars is free to access, and available to view anytime.
The target audience for these sessions are all healthcare professionals, but the lectures will also be of interest to anyone involved in cell and gene therapies. please click on the link of the webinar to register.
- UK Advanced Therapies Remit, 4pm 8th March 2022, Francesca Gliubich (Director UK Advanced Therapies)
- Patient and Public Engagement in the development of cell and gene therapies – why it matters and how to engage with people, 4pm 15th March 2022, members of the national working group for patient and public involvement
- Cell and Gene Therapy UK Ecosystem : “2032 Crystal Ball”, 4pm 22nd March 2022, Ian McCubbin (Chair RoslinCT, Chair Cell and Gene Therapy Catapult; from February 2022)
Past webinars, follow the link to view the webinars on demand (registration required to watch the sessions)
- Out of specification ATMPs, Anne Black (Regional Quality Assurance (QA) Specialist Pharmacist for the North East & North Cumbria, Newcastle upon Tyne Hospitals NHS Foundation Trust)
- Building the UK ecosystem for the delivery of ATMPs, Dr Jacqueline Barry (Chief Clinical Officer, Cell and Gene Therapy Catapult)
- Accelerating delivery of cellular therapy trials, Prof. Charles Craddock (Director of Blood and Marrow Transplant Unit, University Hospitals Birmingham NHS Foundation Trust)
- Standardisation of procurement of starting materials by apheresis for advanced therapies, Dr Lynn Manson (Clinical Lead, SNBTS Therapeutic Apheresis Services)
- Challenges and opportunities for patient reported outcome assessment in the evaluation of advanced therapeutics, 4pm 30th Nov, Prof. Melanie Calvert (Director of the Centre for Patient Reported Outcomes Research)
- Solid tumour treatment, Linda Gomm, Lead cell therapy research nurse and Sophie Papa, Consultant medical oncologist, Guys and St Thomas’
- Advanced therapies and NHS readiness, Ewan Morrison Director of Pharmacy, NHS National Services Scotland
- Advanced therapy landscape in the UK, Matthew Durdy (CEO, Cell and Gene Therapy Catapult)
- Gene editing: scientific basis and clinical potential, Kyriel Pinealt (Research Associate, Imperial College)
- Gene Therapy for respiratory diseases, Eric Alton (Professor of Gene Therapy and Respiratory Medicine, Imperial college)
- Introduction to ATMP manufacturing, Ivan Wall (Professor of Regenerative Medicine, Cell & Gene Therapy Bioprocessing, Aston University)
- Guide to gene therapy, Uta Griesenbach (Prof Molecular medicine, Imperial College London)
- Introduction to cell therapy, Sian Harding (Prof of Cardiac pharmacology, Imperial College London)
- What do I need to know about CAR T cancer therapies? Adam Gibb (Clinical research fellow, The Christie NHS Foundation Trust)
- Institutional readiness: governance and operational considerations for delivering ATMPs in hospitals, Anne Black (Regional QA Specialist Pharmacist, The Newcastle upon Tyne Hospitals NHS Trust)
- Dosing considerations for ATMPs, Amisha Desai, (Advanced Clinical Pharmacist, University Hospitals Birmingham NHS Foundation Trust)
- The unusual case of a rare disease, Spinal Muscular Atrophy, Rafael Yanez (Professor of Advanced Therapy, Royal Holloway)
- ATMPs on the horizon, Joanne McEntee (Senior Medicines Information Pharmacist – Horizon scanning and publications lead
North West Medicines Information Centre) - Patient and public perspectives on advanced therapies, Dr Lee Aiyegbusi, CPROR Deputy Director, University of Birmingham
- Care of CAR-T patients; The nursing perspective, Katie Brice, CAR T Clinical Nurse Specialist, Manchester Royal Infirmary
- ATMPs in paediatrics, Rob Wynn, Consultant Paediatric Haematologist, Royal Manchester Children’s Hospital
- Covid vaccines and ATMP likeness, Peter Openshaw, Professor of Experimental Medicine, Imperial College London
- ATMP treatments for diabetes, James Shaw, Professor of Regenerative Medicine for Diabetes, Newcastle University
- Gene therapies for the eye, 22nd June at 4pm, Jack Hickmott, Research associate, Imperial College London
